AIMT
Aimmune Therapeutics, Inc.
Director Patrick G Enright bought $1.4M of Aimmune Therapeutics, Inc.
Bought$1,420,045
$11.36Price
125,000Shares
+2%Stake
What AIMT did for a copier
Prices for AIMT after this filing aren't in yet.
Patrick G Enright's record
8 other buys with 3 months of prices since 2018: on average −2.1% against the S&P 500, and 1 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Mar 17. Filed Thu, Mar 19, 1:03 PM ET, during the session. Not investment advice.